Home›People›Matthew Shore
MS

Matthew Shore

Director at Frontier Bio Corp

Director
Updated Nov 10, 2026·Latest SEC filing Nov 10, 2026·Suggest an edit

About Matthew Shore

Matthew Shore is a director of Frontier Bio Corp, which develops living blood-vessel grafts that surgeons can attach during an operation.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Shore in the role, so the role may have started earlier or lasted longer.

Frontier Bio Corp Current
Director
2026 – Present · Hayward, CA
Frontier Bio makes living vascular grafts and lab-grown tissue platforms for surgeons and medical researchers.

Key Colleagues at Startups

The people Matthew Shore works with at each company, as listed on that company's latest Form D.

Frontier Bio Corp · Form D, Nov 10, 2026
Eric Bennett
Eric Bennett
CEO and director

Sources

  1. SECFrontier Bio Corp Form D, filed Nov 10, 2026
  2. P1Frontier Bio team
  3. P2Frontier Bio home page